Clinical Trial

Chemotherapy-Induced Peripheral Neuropathy - Additional Evaluation in Breast Cancer Survivors

Name: Chemotherapy-Induced Peripheral Neuropathy - Additional Evaluation in Breast Cancer Survivors — clinical trial record (NCT07604441)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: NEURO-BREAC-02

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The main goal of this trial is to identify the optimal cut-off score of a Scoring System to discriminate between mild chemotherapy-induced peripheral neuropathy (CIPN) and no CIPN in breast cancer survivors previously treated with taxane-based chemotherapy and adjuvant radiotherapy.

Trial Details

NCT Number	NCT07604441
Lead Sponsor	University Hospital Schleswig-Holstein
Conditions	Breast Cancer
Enrollment	28 participants
Start Date	2026-06-01
Primary Completion	2026-08-31 (estimated)
Study Completion	2026-08-31 (estimated)
Updated on ClinicalTrials.gov	2026-05-22